Indo Us Biotech Limited — Others, 16-12-2024: Shareholders meeting

Indo-US Bio-Tech Limited shareholders have passed a resolution to increase the company's authorized share capital from ₹21 crore to ₹32 crore, as detailed in the scrutinizer’s report following the remote e-voting process. A total of 1,47,92,401 votes supported the resolution, reflecting overwhelming approval of 99.9999%. This change allows the company to enhance its equity base, potentially facilitating future growth and expansion initiatives. Investors may view this as a positive outlook, as it demonstrates management's ambition to strengthen the company's financial position and operational capacity.